This page is not indexed by search engines while we improve data quality.

Yungjin Pharmaceutical Co Ltd patents in 2018

Yungjin Pharmaceutical Co Ltd was listed as an assignee on 3 patent publications in 2018.

Company year slice statistics
Metric	Value
Company	Yungjin Pharmaceutical Co Ltd
Year	2018
Patents	3

Patents

Representative publications for Yungjin Pharmaceutical Co Ltd in 2018.

Purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
US-10046019-B2 · Aug 14, 2018 · US
Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient
US-9999646-B2 · Jun 19, 2018 · US
A novel compound (KS-513) isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof
US-2018105548-A1 · Apr 19, 2018 · US

Top CPC classifications

Most common classification codes for Yungjin Pharmaceutical Co Ltd in 2018.

Top CPC codes for Yungjin Pharmaceutical Co Ltd in 2018
CPC	Patents
A23L33/105	3
A61K31/7048	3
A61K36/80	3
A23V2002/00	2
A61K2236/33	2

Related pages

Navigate to parent entity pages.